Jeff Castelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff castelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Castelli Today - Breaking & Trending Today

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Kristen Kluska , Joseph Schwartz , Anupam Rama , Andrew Faughnan , Simon Harford , Ellen Rosenberg , Sebastien Martel , Jeff Castelli , Mitchell Goldman , Fabry Pompe , Ellie Merle , Bradley Campbell , Cantor Fitzgerald , Exchange Commission , Morgan Stanley , Amicus Therapeutics Inc , Biggest Publicly Traded Ai Companies , European Union , Development Officer , Amicus Therapeutics , Call Transcript May , Amicus Therapeutic First Quarter , Results Conference Call , Vice President ,

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript February 28, 2024 Amicus Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics’ Full Year 2023 Financial Results Conference […] ....

United Kingdom , San Diego , United States , Bradley Campbell , Jeff Castelli , Simon Harford , Jeff Gatseli , Asia Pacific , Middle East , Pompe Disease , Chief Development Officer , Amicus Pompe , Annual World Symposium , Treatment Award , Chief Financial Officer , Pompeii Phase , Thanks Simon , Buy According , Future Stocks For The Long , Amicus Therapeutics , Bradley Campbell , Rare Disease , Chief Executive Officer , Jeff Castelli , Chief Medical Officer , Andrew Faughnan ,

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript

Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics Full Year 2023 Financial Results Conference Call and Webcast. ....

United States , United Kingdom , San Diego , Jeff Gatseli , Salveen Richter , Asia Pacific , Simon Harford , Bradley Campbell , Andrew Faughnan , Morgan Stanley , Anupam Rama , Ellen Rosenberg , Malcolm Kuno , Eliana Merle , Mitchell Goldman , Ellie Merle , Jeff Castelli , Joseph Schwartz , Sebastien Martel , Kristen Kluska , Goldman Sachs , Cantor Fitzgerald , Clinical Trial Program , Exchange Commission , Development Officer , Amicus Therapeutics Inc ,

Q3 2024 EPS Estimates for Amicus Therapeutics, Inc. Cut by Analyst (NASDAQ:FOLD)

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Zacks Research decreased their Q3 2024 earnings estimates for shares of Amicus Therapeutics in a report issued on Thursday, January 18th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will earn $0.00 per share for the quarter, down from their prior estimate of $0.01. […] ....

United States , Ellen Rosenberg , Jeff Castelli , Jpmorgan Chase Co , Zacks Research , Amicus Therapeutics Company Profile , Exchange Traded Concepts , Amicus Therapeutics Inc , Securities Exchange Commission , China Universal Asset Management Co , Skyview Investment Advisors , Hr Department , Morgan Stanley , Amicus Therapeutics , Free Report , Amicus Therapeutic , Get Free Report , View Investment Advisors , Traded Concepts , China Universal Asset Management , Universal Asset Management , Exchange Commission , Amicus Therapeutics Daily , Nasdaq Fold , Earnings Estimates ,

Amicus Therapeutics Inc's Chief Development Officer Sells Shares

On December 28, 2023, Jeff Castelli, Chief Development Officer of Amicus Therapeutics Inc (NASDAQ:FOLD), sold 17,421 shares of the company's stock, according to a recent SEC Filing. ....

Amicus Therapeutics Inc , Fairly Valued , Amicus Therapeutics , Biotechnology Company , Chief Development Officer , Fairly Valued , Metabolic Diseases , Jeff Castelli ,